We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity.
- Authors
Seo, Ji A; Kang, Min-Cheol; Yang, Won-Mo; Hwang, Won Min; Kim, Sang Soo; Hong, Soo Hyun; Heo, Jee-In; Vijyakumar, Achana; Pereira de Moura, Leandro; Uner, Aykut; Huang, Hu; Lee, Seung Hwan; Lima, Inês S.; Park, Kyong Soo; Kim, Min Seon; Dagon, Yossi; Willnow, Thomas E.; Aroda, Vanita; Ciaraldi, Theodore P.; Henry, Robert R.
- Abstract
Crosstalk between liver and skeletal muscle is vital for glucose homeostasis. Hepatokines, liver-derived proteins that play an important role in regulating muscle metabolism, are important to this communication. Here we identify apolipoprotein J (ApoJ) as a novel hepatokine targeting muscle glucose metabolism and insulin sensitivity through a low-density lipoprotein receptor-related protein-2 (LRP2)-dependent mechanism, coupled with the insulin receptor (IR) signaling cascade. In muscle, LRP2 is necessary for insulin-dependent IR internalization, an initial trigger for insulin signaling, that is crucial in regulating downstream signaling and glucose uptake. Of physiologic significance, deletion of hepatic ApoJ or muscle LRP2 causes insulin resistance and glucose intolerance. In patients with polycystic ovary syndrome and insulin resistance, pioglitazone-induced improvement of insulin action is associated with an increase in muscle ApoJ and LRP2 expression. Thus, the ApoJ-LRP2 axis is a novel endocrine circuit that is central to the maintenance of normal glucose homeostasis and insulin sensitivity. Hepatokines are proteins secreted by the liver that can regulate whole body metabolism. Here the authors identify apolipoprotein J as a hepatokine that regulates muscle glucose metabolism and insulin resistance through a low-density lipoprotein receptor-related protein−2 mediated mechanism in mice.
- Subjects
MUSCLE metabolism; INSULIN resistance; GLUCOSE metabolism; METABOLIC syndrome; INSULIN receptors; GLUCOSE intolerance; PANCREATIC beta cells; LIVER
- Publication
Nature Communications, 2020, Vol 11, Issue 1, p1
- ISSN
2041-1723
- Publication type
Article
- DOI
10.1038/s41467-020-15963-w